Design, Formulation and Evaluation of Physicochemical Properties of Valacyclovir Effervescent Tablet

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 170

فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TIPS-8-3_002

تاریخ نمایه سازی: 24 آبان 1401

چکیده مقاله:

Valacyclovir (VA) displays antiviral activity against Herpes simplex virus (HSV) and Varicella zoster virus (VZV). The aim of this study was to design, formulate and evaluate the physicochemical properties of effervescent tablets containing VA in order to facilitate pill swallowing for the pediatric, elderly and bed-ridden patients. Sixteen formulations with different amounts of effervescent base were prepared by modified direct compression for the loading of ۵۰۰ mg VA. The Design-Expert® software was then used to generate formulations using a full factorial design with four different variables: citric acid (A), sodium bicarbonate to citric acid molar ratio (B) ۶۰۰۰ (D). The prepared tablets were assessed for weight variation, hardness, thickness, friability, drug content, CO۲ content, effervescence time and pH. To improve the taste of formulations, several sweeteners and fruity essences such as raspberry and cherries were used. F۲ formulation was selected as the optimized formulation with the desirability of ۷۲.۸%. The optimized formulation had an effervescent time of ۹۸.۳۳±۳.۵۱ seconds, friability % of ۰.۵۵, pH value of ۴.۶۷±۰.۰۶, CO۲ amount of ۲۶۱.۳۳ ± ۲۰.۲۶ mg and hardness of ۷۷.۲۳±۳.۱۲ N. It, therefore, seems that optimized effervescent tablets may be helpful for the delivery of VA in the treatment of herpes simplex or herpes zoster and chikenpox. Keywords: Valacyclovir, Effervescent Tablet, Dry Granulation, Direct compression method. Please cite this article as: Somayeh Taymouri, Abolfazl Mostafavi, Sajjad Zaretaghiabadi. Design, Formulation and Evaluation of Physicochemical Properties of Valacyclovir Effervescent Tablet. Trends in Pharmaceutical Sciences. ۲۰۲۲;۸(۳):۱۳۵-۱۴۶. doi: ۱۰.۳۰۴۷۶/TIPS.۲۰۲۲.۹۵۳۸۵.۱۱۴۵.

نویسندگان

Somayeh Taymouri

School of Pharmacy and Novel Drug Delivery Systems Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

Abolfazl Mostafavi

Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Sajjad Zaretaghiabadi

Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Tekade B, Jadhao U, Thakare V, Bhortake L. Formulation and ...
  • Rajlakshmi G, Vamsi C, Balchandar R, Damodharan N. Formulation and ...
  • Palanisamy P, Abhishekh R, Yoganand Kumar D. Formulation and evaluation ...
  • Beutner KR. Valacyclovir: a review of its antiviral activity, pharmacokinetic ...
  • Vigil KJ, Chemaly RF. Valacyclovir: approved and off-label uses for ...
  • Kechagia IA, Kalantzi L, Dokoumetzidis A. Extrapolation of Valacyclovir Posology ...
  • Azouz L, Dahmoune F, Rezgui F, G'Sell C. Full factorial ...
  • The United States pharmacopeia ۴۳. Na­tional formulary ۳۸.Vol. ۵. Rockville ...
  • The United States pharmacopeia ۴۳. Na­tional formulary ۳۸.Vol. ۴. Rockville ...
  • Rani KC, Parfati N, Jayani NI, Kurniawan I, Kristiani NP. ...
  • نمایش کامل مراجع